Investor's Calendar
Last News

ROVI has obtained the best ESG score from among the 458 companies evaluated in its pharmaceutical subindustry...
2 min
01 Aug, 2022

ROVI reports operating revenue growth of 31% and net profit growth of 58%
3 min
27 Jul, 2022

EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
4 min
19 Jul, 2022
Public statements sent to CNMV
ESG
Discover what ROVI is doing to become a more sustainable company
CORPORATE GOVERNANCE
Find out more about ROVI’s main governing bodies
Information for investors

Marta Campos
Head of Investor Relations

Antonio Marquina
Investor Relations
